vs
CODEXIS, INC.（CDXS）与Gevo, Inc.（GEVO）财务数据对比。点击上方公司名可切换其他公司
Gevo, Inc.的季度营收约是CODEXIS, INC.的1.2倍（$45.3M vs $38.9M）。CODEXIS, INC.净利率更高（24.7% vs -13.2%，领先37.9%）。Gevo, Inc.同比增速更快（695.6% vs 81.3%）。CODEXIS, INC.自由现金流更多（$19.6M vs $8.7M）。过去两年Gevo, Inc.的营收复合增速更高（237.1% vs 51.0%）
科迪西斯是一家专注于蛋白质工程的企业，核心业务是开发可应用于制药、食品及医疗领域的酶制剂，依托自身技术优势为相关行业提供高性能的生物催化解决方案，助力生命科学与食品加工领域的技术升级。
Gevo公司是总部位于美国科罗拉多州道格拉斯县的可再生化学品与先进生物燃料企业，聚焦可持续发展领域，围绕循环经济开展业务。公司结合生物技术与传统化学技术，开发生物基产品替代石油基产品，致力于推动减碳可持续转型。
CDXS vs GEVO — 直观对比
营收规模更大
GEVO
是对方的1.2倍
$38.9M
营收增速更快
GEVO
高出614.2%
81.3%
净利率更高
CDXS
高出37.9%
-13.2%
自由现金流更多
CDXS
多$10.8M
$8.7M
两年增速更快
GEVO
近两年复合增速
51.0%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $38.9M | $45.3M |
| 净利润 | $9.6M | $-6.0M |
| 毛利率 | 94.8% | — |
| 营业利润率 | 27.1% | -4.8% |
| 净利率 | 24.7% | -13.2% |
| 营收同比 | 81.3% | 695.6% |
| 净利润同比 | 192.5% | 65.9% |
| 每股收益（稀释后） | $0.13 | $-0.03 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CDXSGEVO
| Q4 25 | $38.9M | $45.3M | ||
| Q3 25 | $8.6M | $42.7M | ||
| Q2 25 | $15.3M | $43.4M | ||
| Q1 25 | $7.5M | $29.1M | ||
| Q4 24 | $21.5M | $5.7M | ||
| Q3 24 | $12.8M | $2.0M | ||
| Q2 24 | $8.0M | $5.3M | ||
| Q1 24 | $17.1M | $4.0M |
净利润CDXSGEVO
| Q4 25 | $9.6M | $-6.0M | ||
| Q3 25 | $-19.6M | $-8.0M | ||
| Q2 25 | $-13.3M | $2.1M | ||
| Q1 25 | $-20.7M | $-21.7M | ||
| Q4 24 | $-10.4M | $-17.6M | ||
| Q3 24 | $-20.6M | $-21.2M | ||
| Q2 24 | $-22.8M | $-21.0M | ||
| Q1 24 | $-11.5M | $-18.9M |
毛利率CDXSGEVO
| Q4 25 | 94.8% | — | ||
| Q3 25 | 71.3% | — | ||
| Q2 25 | 86.3% | — | ||
| Q1 25 | 63.8% | — | ||
| Q4 24 | 83.0% | — | ||
| Q3 24 | 66.4% | — | ||
| Q2 24 | 56.6% | — | ||
| Q1 24 | 71.6% | — |
营业利润率CDXSGEVO
| Q4 25 | 27.1% | -4.8% | ||
| Q3 25 | -220.3% | -8.6% | ||
| Q2 25 | -83.9% | 13.4% | ||
| Q1 25 | -271.6% | -69.2% | ||
| Q4 24 | -34.2% | -344.7% | ||
| Q3 24 | -129.0% | -1221.8% | ||
| Q2 24 | -284.9% | -456.8% | ||
| Q1 24 | -69.6% | -580.0% |
净利率CDXSGEVO
| Q4 25 | 24.7% | -13.2% | ||
| Q3 25 | -228.1% | -18.6% | ||
| Q2 25 | -86.6% | 4.9% | ||
| Q1 25 | -274.3% | -74.6% | ||
| Q4 24 | -48.4% | -308.9% | ||
| Q3 24 | -160.8% | -1076.6% | ||
| Q2 24 | -285.2% | -399.3% | ||
| Q1 24 | -67.4% | -473.1% |
每股收益（稀释后）CDXSGEVO
| Q4 25 | $0.13 | $-0.03 | ||
| Q3 25 | $-0.22 | $-0.03 | ||
| Q2 25 | $-0.16 | $0.01 | ||
| Q1 25 | $-0.25 | $-0.09 | ||
| Q4 24 | $-0.12 | $-0.08 | ||
| Q3 24 | $-0.29 | $-0.09 | ||
| Q2 24 | $-0.32 | $-0.09 | ||
| Q1 24 | $-0.16 | $-0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $78.2M | $81.2M |
| 总债务越低越好 | $40.1M | $164.8M |
| 股东权益账面价值 | $50.5M | $466.3M |
| 总资产 | $147.8M | $718.9M |
| 负债/权益比越低杠杆越低 | 0.79× | 0.35× |
8季度趋势，按日历期对齐
现金及短期投资CDXSGEVO
| Q4 25 | $78.2M | $81.2M | ||
| Q3 25 | $58.7M | $72.6M | ||
| Q2 25 | $66.3M | $57.3M | ||
| Q1 25 | $59.8M | $65.3M | ||
| Q4 24 | $73.5M | $189.4M | ||
| Q3 24 | $90.3M | $223.2M | ||
| Q2 24 | $73.2M | $245.7M | ||
| Q1 24 | $85.5M | $270.6M |
总债务CDXSGEVO
| Q4 25 | $40.1M | $164.8M | ||
| Q3 25 | $39.7M | $164.5M | ||
| Q2 25 | $39.4M | $167.5M | ||
| Q1 25 | $29.2M | $167.0M | ||
| Q4 24 | $28.9M | $67.1M | ||
| Q3 24 | $28.6M | $67.0M | ||
| Q2 24 | $28.4M | $66.8M | ||
| Q1 24 | $28.1M | $68.3M |
股东权益CDXSGEVO
| Q4 25 | $50.5M | $466.3M | ||
| Q3 25 | $38.5M | $468.9M | ||
| Q2 25 | $55.6M | $474.1M | ||
| Q1 25 | $49.6M | $469.8M | ||
| Q4 24 | $66.9M | $489.5M | ||
| Q3 24 | $73.4M | $504.7M | ||
| Q2 24 | $61.4M | $522.7M | ||
| Q1 24 | $79.3M | $541.9M |
总资产CDXSGEVO
| Q4 25 | $147.8M | $718.9M | ||
| Q3 25 | $124.0M | $685.2M | ||
| Q2 25 | $138.2M | $702.1M | ||
| Q1 25 | $128.9M | $677.8M | ||
| Q4 24 | $149.0M | $583.9M | ||
| Q3 24 | $148.2M | $583.9M | ||
| Q2 24 | $132.0M | $617.9M | ||
| Q1 24 | $149.6M | $633.6M |
负债/权益比CDXSGEVO
| Q4 25 | 0.79× | 0.35× | ||
| Q3 25 | 1.03× | 0.35× | ||
| Q2 25 | 0.71× | 0.35× | ||
| Q1 25 | 0.59× | 0.36× | ||
| Q4 24 | 0.43× | 0.14× | ||
| Q3 24 | 0.39× | 0.13× | ||
| Q2 24 | 0.46× | 0.13× | ||
| Q1 24 | 0.35× | 0.13× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $20.1M | $20.0M |
| 自由现金流经营现金流 - 资本支出 | $19.6M | $8.7M |
| 自由现金流率自由现金流/营收 | 50.3% | 19.3% |
| 资本支出强度资本支出/营收 | 1.3% | 24.7% |
| 现金转化率经营现金流/净利润 | 2.09× | — |
| 过去12个月自由现金流最近4个季度 | $-23.8M | $-43.5M |
8季度趋势，按日历期对齐
经营现金流CDXSGEVO
| Q4 25 | $20.1M | $20.0M | ||
| Q3 25 | $-7.7M | $-6.8M | ||
| Q2 25 | $-18.0M | $-2.5M | ||
| Q1 25 | $-13.8M | $-24.0M | ||
| Q4 24 | $-16.5M | $-18.8M | ||
| Q3 24 | $-13.0M | $-11.0M | ||
| Q2 24 | $-12.2M | $-11.4M | ||
| Q1 24 | $-7.8M | $-16.1M |
自由现金流CDXSGEVO
| Q4 25 | $19.6M | $8.7M | ||
| Q3 25 | $-7.9M | $-14.6M | ||
| Q2 25 | $-20.5M | $-7.8M | ||
| Q1 25 | $-15.1M | $-29.9M | ||
| Q4 24 | $-18.2M | $-33.5M | ||
| Q3 24 | $-14.0M | $-20.8M | ||
| Q2 24 | $-12.6M | $-20.6M | ||
| Q1 24 | $-8.9M | $-33.6M |
自由现金流率CDXSGEVO
| Q4 25 | 50.3% | 19.3% | ||
| Q3 25 | -91.7% | -34.2% | ||
| Q2 25 | -133.6% | -17.9% | ||
| Q1 25 | -199.6% | -102.7% | ||
| Q4 24 | -85.0% | -587.2% | ||
| Q3 24 | -109.0% | -1057.0% | ||
| Q2 24 | -157.5% | -392.4% | ||
| Q1 24 | -52.2% | -841.9% |
资本支出强度CDXSGEVO
| Q4 25 | 1.3% | 24.7% | ||
| Q3 25 | 2.1% | 18.3% | ||
| Q2 25 | 16.4% | 12.1% | ||
| Q1 25 | 16.7% | 20.0% | ||
| Q4 24 | 8.3% | 256.6% | ||
| Q3 24 | 7.8% | 496.2% | ||
| Q2 24 | 5.0% | 174.8% | ||
| Q1 24 | 6.6% | 438.9% |
现金转化率CDXSGEVO
| Q4 25 | 2.09× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -1.18× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
